Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Pet cremation urn
Display screen with graphical user interface
Transmission apparatus and network protection method
Emergent information database management system
Conductor for transmitting electrical power
MiR 204, miR 211, their anti-miRs, and therapeutic uses of same
5-HT.sub.3 receptor modulators, methods of making, and use thereof
  Randomly Featured Patents
Optical method for measuring poisson's ratio
Rotating head assembly
Method of fabricating quantum wire semiconductor laser via photo induced evaporation enhancement during in situ epitaxial growth
Molding retainer
Electro-optical color imaging apparatus
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in d
Color filter substrate, electronic apparatus and manufacturing method thereof
Toughened glass ceramic substrates for semiconductor devices subjected to oxidizing atmospheres during sintering
Shipping and display case
Exterior protective cover for automobile front windshield